Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

Clinical trial NCT00074165 · TERMINATED

Trial details

NCT number: NCT00074165
Sponsor: OHSU Knight Cancer Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors Drug/Agent Toxicity by Tissue/Organ Lymphoma Thrombocytopenia

Start date: 2003-01-01
Primary completion: 2010-06-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.